Yan J, Yao B, Kuang H et al (2019) Liraglutide, sitagliptin, and insulin glargine added to metformin: the effect on body weight and intrahepatic lipid in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
Compound: Melanotan II (MT-II) Concentration: 10mg per vial Format: Lyophilized White Powder (Strictly for In-Vitro Laboratory Use) Chemical Classification: Non-Selective Melanocortin Receptor Agonist Chemical Profile: Melanotan II (MT-II) is a synthetic cyclic heptapeptide derived from the alpha-melanocyte-stimulating hormone (-MSH) structure
This is the application area with the deepest preclinical history, and it is also where oral administration has a particularly direct anatomical rationale - the compound passes through the GI tract it was originally studied in relation to
If approved, your medication will be delivered discreetly to your door
KellerGAColaianniICoriaJDi GirolamoGMirandaS
Developing pharmacological agents that specifically target SRXN1 and understanding its broader implications across different tissues and disease states will be crucial steps in advancing SRXN1-based therapies